Dynamic Medicine — Part V Clinical Trials in a Dynamic Disease World Why Linear Randomization Fails to Capture Instability, Timing, and Bias

This paper examines a structural limitation in modern clinical trial design: the mismatch between dynamic disease processes and largely static experimental frameworks. While randomized controlled trials remain the cornerstone of evidence-based medicine, most trial architectures assume relatively stable disease states and phase-insensitive treatment allocation. Drawing on concepts from complex systems science and the Universal Resonance Model (URM), the paper argues that many clinically important events—such as inflammatory flares, sepsis, and acute systemic deterioration—represent rapid system transitions rather than steady disease states. Under such conditions, baseline randomization and fixed endpoints may obscure timing-dependent treatment effects. The article therefore proposes that instability, system phase, and temporal dynamics should become explicit considerations in future trial design. Recognizing disease as a dynamic process may improve both evidence generation and the safety of AI systems trained on clinical trial data.